Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLYGLU: MTX-PG Concentration and Clinical Response in RA
NCT03445871Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jul 2018
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methotrexate in rheumatoid arthritis (RA), sponsored by CHU Saint-Etienne. Started Jul 2018; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03445871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445871.